Combined negative effect of donor age and time in culture on the reprogramming efficiency into induced pluripotent stem cells  by Trokovic, Ras et al.
Ava i l ab l e on l i ne a t www.sc i enced i r ec t . com
ScienceDirect
www.e l sev i e r . com / l oca te / s c r
Stem Cell Research (2015) 15, 254–262Combined negative effect of donor age and
time in culture on the reprogramming
efficiency into induced pluripotent stem cells
Ras Trokovic a,1, Jere Weltner a,1, Parinya Noisa b,c,
Taneli Raiviob,d, Timo Otonkoski a,d,⁎a Research Programs Unit, Molecular Neurology, Biomedicum Stem Cell Center, University of Helsinki, Helsinki, Finland
b Institute of Biomedicine, Department of Physiology, University of Helsinki, Helsinki, Finland
c School of Biotechnology, Institute of Agricultural Technology, Suranaree University of Technology, Nakhon Ratchasima, Thailand
d Children's Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
Received 30 April 2014; received in revised form 1 June 2015; accepted 5 June 2015
Available online 11 June 2015Abstract
Somatic cells can be reprogrammed into induced pluripotent stem cells (iPSC) by the forced expression of the transcription
factors OCT4, SOX2, KLF4 and c-MYC. Pluripotent reprogramming appears as a slow and inefficient process because of genetic
and epigenetic barriers of somatic cells. In this report, we have extended previous observations concerning donor age and
passage number of human fibroblasts as critical determinants of the efficiency of iPSC induction. Human fibroblasts from 11
different donors of variable age were reprogrammed by ectopic expression of reprogramming factors. Although all fibroblasts
gave rise to iPSC colonies, the reprogramming efficiency correlated negatively and declined rapidly with increasing donor age.
In addition, the late passage fibroblasts gave less reprogrammed colonies than the early passage cell counterparts, a finding
associated with the cellular senescence-induced upregulation of p21. Knockdown of p21 restored iPSC generation even in
long-term passaged fibroblasts of an old donor, highlighting the central role of the p53/p21 pathway in cellular senescence
induced by both donor age and culture time.
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Table 1 Information on donors of fibroblasts used in this
study.







2 Skin fibroblast 1 Female PNDM
3 Skin fibroblast 14 Female PNDM
4 Skin fibroblast 18 Male PNDM
5 Skin fibroblast 22 Female Healthy
6 Skin fibroblast 32 Female PNDM
7 Skin fibroblast 43 Female Healthy
8 Skin fibroblast 49 Male Healthy
9 Skin fibroblast 57 Female Healthy
10 Skin fibroblast 81 Male Healthy
11 Skin fibroblast 83 Male Healthy
PNDM, Permanent Neonatal Diabetes Mellitus.
255Combined effect of age and culture time on reprogramming efficiencyof somatic cells have been successfully used for iPSC
derivation, including for instance skin fibroblasts, blood
cells and myoblasts (Seki et al., 2010; Trokovic et al., 2013,
2014; Yu et al., 2007). Alternative methods for iPSC
derivation have been intensively developed to avoid the
integration of transgenes, including reprogramming in-
duced by Sendai virus, mRNA, episomal vectors or small
molecules (Hou et al., 2013; Nishimura et al., 2011; Warren
et al., 2010; Zhou et al., 2009). Although methods for iPSC
derivation have been intensively developed, most current
technologies are still inefficient, which may be due to
intrinsic barriers in the ability of cells to undergo a rapid
shift in their proliferative rate (Hanna et al., 2009; Smith et
al., 2010).
Multiple factors are known to contribute to the efficiency of
iPSC generation (Park et al., 2014). For example, differentiation
state of the starting cell is a significant factor, since progenitors
and stem cells give higher reprogramming efficiency than
terminally differentiated cells (Eminli et al., 2009). There is also
evidence for varying efficiency for different types of somatic
cells from the same donor (Streckfuss-Bomeke et al., 2013). In
addition cellular senescence has been shown to affect the
reprogramming efficiency (Banito et al., 2009; Kawamura et
al., 2009; Li et al., 2009; Marión et al., 2009; Utikal et al.,
2009). Cellular senescence increases with age and one of its
hallmarks is the irreversible cell cycle arrest through the
activation of the p53/p21 and p16 pathways (Campisi and
d'Adda di Fagagna, 2007; Narita et al., 2003). These findings
suggest that intrinsic properties of somatic cells determine the
reprogramming efficiency.
Donor age has been shown to have an effect on re-
programming efficiency of murine cells (Wang et al., 2011).
Contrary to what has been observed in mice, donor age was
suggested not to impair the reprogramming efficiency of
human cells (Somers et al., 2010) and iPSC have been
successfully derived even from the fibroblasts of centenarians
(Lapasset et al., 2011). However, there are no reports on the
combined effect of age and culture time on reprogramming
efficiency of human cells.
The aim of this report was to evaluate the independent
and combined impact of donor age and passage number on
the pluripotent reprogramming efficiency of human dermal
fibroblasts. Gene expression profiles of selected genes and
telomere lengths of starting fibroblasts were analyzed in order
to identify potential factors behind distinct reprogramming
efficiencies. We found that the reprogramming efficiency of
human dermal fibroblasts is synergistically affected by donor
age and culture time, both inducing cellular senescence
through the p53/p21 pathway.Materials and methods
Ethics, description of the human material
Donors or their guardians provided their written informed
consent for participation. Coordinating Ethics Committee of
Helsinki and Uusimaa Hospital District approved generation
and use of human iPSC (statement nr. 423/13/03/00/08) on
April 2009. Human dermal fibroblasts and foreskin fibro-
blasts (HFF; CRL-2429; ATCC) were used for reprogramming
(Table 1).Cell culture and fibroblasts reprogramming
Human foreskin fibroblasts (CRL-2429, ATCC) and dermal
fibroblasts that were derived from skin biopsies were cultured
in DMEM (Sigma) supplementedwith 10% FBS (Life Technologies)
and GlutaMAX (Life Technologies) (Table 1). Human induced
pluripotent stem cells were cultured in hESC medium: DMEM/
F12 with GlutaMAX (Life Technologies), 10% knockout serum
replacement (Life Technologies), 0.1 mM 2-mercapthoetanol
(Life Technologies), 1× non-essential amino acids (Life Tech-
nologies), and 6 ng/ml bFGF (Sigma) or E8 (Life Technologies)
on matrigel and routinely propagated with combination of
collagenase IV treatment andmechanic dissociation. Fibroblasts
were reprogrammed using four Yamanaka factors (OCT4, SOX2,
KLF4, and C-MYC) using pMXs retroviruses or Sendai viruses: SeV
(Cytotune; Life Technologies), or SeVdp (Nishimura et al., 2011)
onmatrigel and E6medium (Life Technologies) and as described
previously (Hussein et al., 2011; Trokovic et al., 2013, 2014).
To enhance the reprogramming of fibroblasts 0.25 mM
sodium butyrate (NaB; Sigma, B5887) was added to all re-
programming experiments. In order to rescue cells from
senescence siRNA targeting human CDKN1A (p21) was obtain-
ed from Dharmacon (M-003471-00-0005). Daily transfections
were performed using 10 pmol siRNA with Lipofectamine
RNAiMAX Reagent (Life Technologies). siRNAwas administered
on the daily basis in duration of 20 days, starting five days
prior Sendai virus infection. To show that an increase in p21
expression reduces reprogramming efficiency, p21 followed
by puromycin N-acetyl-transferase (PAC) was cloned into
pMXs vector and added to the reprogramming cocktail. As a
control pMXs_EGFP_PAC vector was used. To ensure that all
fibroblasts contained vectors with p21 or EGFP, we added
puromycin to the media for the duration of reprogramming.
Immunocytochemistry and alkaline
phosphatase staining
Cells were fixed at room temperature with 4% paraformal-
dehyde for 10 min. Non-specific proteins were blocked by
ultra V block (Thermo). The cells were then treated with
primary antibodies overnight at 4 °C. Primary antibodies
256 R. Trokovic et al.were against TRA-1-60 (1:500, MA1-023, Thermo Fisher), OCT4
(1:500, C30A3, Cell Signaling), SSEA3 (1:100, MAB4303,
Millipore). After washing with PBS, the cells were incubated
with fluorescence-conjugated secondary antibody AlexaFluor
488: donkey anti-goat (1:500, A11055, Life Technologies), goat
anti-mouse (1:500, A21042, Life Technologies), and goat
anti-rat (1:500, A21212, Life Technologies) for 45 min, and
finally mounted to the cover-slip with Vectashield mounting
mediumwith DAPI (Vectorlabs). Alkaline-phosphatase (AP) was
detected using NBT/ BCIP solution (Roche Applied Science).
For live cell staining the cells were incubated with
primary antibody against TRA-1-60 (1:50, MA1-023, Thermo
Fisher) and fluorescence-conjugated secondary antibody
AlexaFluor 488 goat anti-mouse (1:50, A21042, Life Tech-
nologies) for 1 h at 37 °C and 5% CO2 and visualized under
the EVOS fluorescence microscope (Life Technologies).
Western blotting
Cell samples for protein analysis were collected from confluent
6 cm dishes and cell pellets were resuspended in RIPA buffer.
Protein amounts were measured from the supernatant using
Protein Quantification Assay (Macherey & Nagel). 40 μg of
protein per sample was used for SDS-PAGE. Proteins were
transferred onto nitrocellulose membranes using iBlot dry
blotting system (Life Technologies). Membranes were blocked
with TBST + 5% milk powder and p21 primary antibody
incubations were made overnight. HRP-conjugated secondary
antibodies were incubated in room temperature for 1 h.
Proteins were detected using Amersham ECL Prime Western
Blotting Detection Reagent (GE healthcare). The following
antibodies were used: mouse anti-p21 (556431, Pharmingen,
1:500), Actin-HRP (sc-1616 HRP, Santa Cruz, 1:2000),
anti-mouse HRP (7076P2, Cell Signaling, 1:2000).
Teratoma formation
About 200,000 morphologically intact iPSC were intrates-
ticularly injected into male NMRI nude mice (Scanbur). The
resulting tumors were collected 8 weeks after injection,
fixed with 10% formalin, and hematoxylin and eosin stained.
The experimental animal welfare committee of the District
Government of Southern Finland approved the animal
experiments.
Reverse transcription and quantitative PCR (qPCR)
Total RNA was extracted using RNA Spin II (Macherey-Nagel) by
following the manufacturer's instructions. Briefly, first-strand
cDNA was synthesized from 2 μg total RNA by SuperScript III
reverse transcriptase (Invitrogen) with oligo dT primer
(Invitrogen) in 20 μl volume. 1% of above cDNA was used for
each qPCR reaction in a 20 μl mixture containing 10 μl of SYBR
green-Taq mixed solution (Sigma) and 5 μl of 2 μM-primer
mix. PCR reactions were carried out in a Corbette thermal
cycler (Qiagen) for 40 cycles and each cycle contained 95 °C
for 15 s, 60 °C for 30 s and 72 °C for 30 s. RNAwithout reverse
transcription was used as a negative control. The relative
expression level of genes was calculated by calibrating their
CT values with that of the housekeeping gene Cyclophilin G,and normalized to fibroblasts at passage 6 (as reference
sample). List of primers is provided in Supplementary Table 1.
Telomere measurement
DNA was isolated from fibroblasts by genomic DNA extraction
kit (Invitrogen) for telomere measurement. Telomere length
was measured as previously described (Cawthon, 2002) by
qPCR amplification with oligonucleotide primers designed to
hybridize to the TTAGGG and CCCTAA repeats. For all qPCR
reactions, SYBR® Green JumpStart™ Taq ReadyMix™ (Sigma)
was used for both T and S qPCR. The final telomere primer
concentrations were as follows: tel 1, 270 nM and tel 2,
900 nM. The final 36B4 (single copy gene) primer concen-
trations were 36B4u, 300 nM and 36B4d, 500 nM. Primer
sequences (5′ → 3′) were as follows: tel 1, GGTTTTTGAGG
GTGAGGGTGAGGGTGAGGGTGAGGGT; tel 2, TCCCGACTATCC
CTATCCCTATCCCTATCCCTATCCCTA; 36B4u, CAGCAAGTGG
GAAGGTGTAATCC; 36B4d, CCCATTCTATCATCAACGGGTACAA
(Mondello et al., 1999). All PCRs were performed using
LightCycler® 480 by Roche thermocycler. For telomere PCR,
40 cycles of 95 °C for 15 s, 54 °C for 2 min, and for 36B4 PCR,
40 cycles of 95 °C for 15 s, 58 °C for 1 min were set.
Telomere length LightCycler® 480 by Roche thermocycler
was used to generate the standard curve for each run and to
determine the dilution factors of standards corresponding to
the T and S amounts in each sample. Absolute quantification
results for both T and S were obtained using the Second
Derivative Maximum method with the LightCycler® 480 Soft-
ware v. 1.5. The relative telomere length value was expressed
as the average of duplicate telomere over the average of
duplicate single copy gene (T/S) ratio. All presented telomere
length displayed as a relative level, compared to fibroblasts#1,
passage 6. Standard deviation (s.d.) was obtained from three
replicate values of each fibroblast sample, and statistical
analysis was performed by Student's t test.
CELL-IQ imaging
The early and late passage fibroblasts were taken into the
Cell-IQ cell imaging system (ChipMan Technologies, Tampere,
Finland) and visualized for 90 h to quantify the number of
proliferative cells.
Statistical analysis
To correlate the donor age and reprogramming efficiency we
used linear regression carried out on reprogramming efficien-
cy mean value (n = 4, two independent experiments) for
donor fibroblasts (n = 11) of various ages. Pearson's correla-
tion coefficient and p value were calculated using Graph Pad
Prism 6 software. Student t-test was used for statistical
evaluation of iPSC reprogramming from early and late passage
fibroblasts. A p value b 0.05 was considered statistically
significant.
Results and discussion
Pluripotency can be induced from somatic cells by the forced
expression of the reprogramming factors OCT4, SOX2, KLF4
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reprogramming, we studied human dermal fibroblasts from
skin biopsies of 11 individuals representing different ages
(0–83 years). The donors were either healthy volunteers or
patients suffering from neonatal onset diabetes mellitus
(PNDM) (Table 1). Although unlikely, we cannot exclude the
possibility that the mutations causing PDNM may have had
an effect on the reprogramming efficiency. The fibroblast
outgrowths (passage 0) were cultured to establish cell lines
for further experiments. Fibroblasts at early passage (p6)
were transduced with retroviruses encoding OCT4, SOX2 KLF4
and c-MYC, and culture conditions were changed as shown
(Fig. 1A). iPSC colonies emerged by day 10 after the induction
(Fig. 1B). To compare iPSC-reprogramming efficiency among
various donor ages (0–83 years), the emerging iPSC colonies
with clear hESC morphology and positive for alkaline phos-
phatase (AP) staining were counted (Fig. 1B–D). Significantly,
reprogramming efficiency correlated negatively and declined
rapidly with increasing donor age (Fig. 1C and D).
We next asked what the impact of culture-induced
senescence of the fibroblasts was on the reprogramming
efficiency. Four representative fibroblast lines from youngFigure 1 Retroviral iPSC induction and characterization of the e
presentation of iPSC induction using pMXs retroviruses. Fibroblasts wer
hESC culture conditions supplemented with sodium butyrate (NaB)
during the reprogramming process. Efficiency was calculated as the to
alkaline phosphatase (AP) at day 21. C) Correlation of reprogrammin
sample (n = 4, two independent experiments). D) Representative imag(ages 0 and 1 year) and old (ages 81 and 83 year) donors were
propagated for up to 25 passages (Fig. 2A). The pluripotent
reprogramming efficiency of early and late passage fibroblasts
was studied by counting AP-positive iPSC colonies with
hESC-like morphology 21 days after the induction by non-
integrating Sendai viral vectors. Regardless of donor age, early
passage fibroblasts yielded significantly more iPSC colonies
than late passage cells (Fig. 2B–D and Supplementary Fig. 2A).
Similar to retroviral inductions, we observed the difference
in reprogramming efficiencies of young (age 0, 1) and old
fibroblasts (age 81, 83) when using Sendai viruses (Fig. 2C and
D and Supplementary Fig. 2A).
Although the older fibroblasts gave only few iPSC colonies,
the iPSC lines (HEL24.3 and HEL47.2) generated from neonatal
and 83-year old donors, respectively (Trokovic et al., 2015),
exhibited normal pluripotent stem cell properties, including
the expression of the stem cell markers NANOG, TRA-1-60,
OCT4, and SSEA3, as shown by immunocytochemistry (Supple-
mentary Fig. 1A). All iPSC lines had activated the transcription
of the endogenous pluripotency genes OCT4, SOX2, NANOG,
and TDGF1 (Supplementary Fig. 1B). Both iPSC lines were
negative for Sendai virus vectors as shown byffect of donor age on reprogramming efficiency. A) Schematic
e transduced at days 0 and 1, (arrowheads) prior to transferring to
. B) Phase contrast images of representative fibroblasts (HFF)
tal number of iPSC colonies with hESC-like morphology positive for
g efficiency with donor age. The mean ± SEM is shown for each
es of AP staining for all donors at 21 days after start of induction.
Figure 2 Sendai virus iPSC induction and characterization of the combined effect of donor age and passaging on reprogramming
efficiency, telomere length and cell growth. A) Schematic presentation of the experimental protocol using Sendai viruses (SeV) for
reprogramming. B) The effect of passage number (white column, p6; black column, p25) on reprogramming efficiency (n = 6; from three
independent fibroblast lines, Supplementary Fig. 2A. *p b 0.05; Student's t-test). C) Combined effect of age and passage number on
reprogramming efficiency of fibroblasts from 1-year (red), 14-year (black), 81-year (green), and 83-year (blue) old donors at passages 4, 10,
and 20. D) Representative images of AP staining at day 21 after the start of induction shown for fibroblasts from 1-, 14-, 81-, and 83-year old
donors at passages 4, 10 and 20. E) Telomere length of fibroblasts determined by quantitative PCR (qPCR) and presented as the relative
telomere to single copy gene (T/S) ratio. Newborn fibroblasts at passage 6 were used as a reference sample. Passage 6 (white bars), passage
25 (black bars). Data are presented as mean ± SD (n = 3; three independent experiments. **p b 0.01 and *p b 0.05; Student's t-test).
F) Doubling time of fibroblasts from 1-, 14-, 81-, and 83-year old donors measured at passages 4, 10, and 20. G) Correlation of doubling times
with donor age. Pearson's correlation has been calculated for all fibroblasts at passage 6 (n = 3).
258 R. Trokovic et al.immunocytochemistry and qPCR (Supplementary Fig. 1A and
B). Multi-lineage differentiation capacity into all three-germ
line lineages was demonstrated by teratoma formation
(Supplementary Fig. 1C). Karyotype of iPSC line HEL24.3
(p14) was 46,XY and HEL47.2 (p14) 46,X, abn (Y). Thekaryotype of the respective donor fibroblasts of HEL47.2 was
also found to be 46,X, abn (Y).
Cellular aging in vitro was determined by cell prolifera-
tion and telomere length. Telomere length, which has been
associated with human aging (Marion et al., 2009), was
259Combined effect of age and culture time on reprogramming efficiencysignificantly shortened by prolonged culture of all fibroblasts
(Fig. 2E). In accordance with telomere length, proliferation
rate of the fibroblasts, examined by live-cell imaging, was
reduced in all long-term cultured samples (Fig. 2F and
Supplementary Fig. 2B). With increasing time in culture, the
population doubling times of fibroblasts from 0 and 1-year old
donors increased from 18 to 20 and 18 to 33 h, respectively.
Similarly, fibroblasts from the 83-year old donor showed a
marked elongation of doubling time, from 21 to 33 h. We then
assessed the proliferation rate of all donor fibroblast lines, at
passages 6–8, and observed a significant positive correlation
between increasing age and doubling time (Fig. 2G).
To uncover the possible mechanisms underlying the dif-
ferences in reprogramming efficiency, expression of selected
genes controlling cell cycle and apoptosis were investigated.
The genes were selected based on previous reports of their
role in iPSC reprogramming (Hong et al., 2009; Li et al., 2013).
In mammalian cells, permanent growth arrest is achieved
through one of the two signaling pathways p53/p21 and p16/
Rb (Choudhury et al., 2007; Wright and Shay, 1992). Notably,
p21 was dramatically upregulated in long term-cultured
fibroblasts, while there was no change in p16, p53 or PUMA
expression (Fig. 3A). Besides the upregulation of p21, long
term-cultured fibroblasts displayed significant shortening of
telomeres (Fig. 2E). This observation was in line with the role
of p21 in mediating senescence in response to telomere
dysfunction (Brown et al., 1997). As p21 inhibition has been
demonstrated to enhance reprogramming efficiency predom-
inantly by the cell division rate-dependent mechanisms
(Hanna et al., 2009), it is likely that the reduction of cell
proliferation and reprogramming efficiency coinciding with
the increase in p21 expression are mechanistically related in
reducing reprogramming efficiency. Our data show that both
donor age and passage number are strongly correlated with
increasing p21 expression (Fig. 3B and C), indicating cellular
senescence-induced upregulation of p21.
Our results are in line with previous findings showing that
cellular senescence negatively correlates with reprogramming
efficiency (Banito et al., 2009; Mali et al., 2008; Qin et al.,
2007; Zhao and Daley, 2008; Zhao et al., 2008). The expression
of p21 is controlled by p53 during the replicative senescence of
normal human fibroblasts (Jackson and Pereira-Smith, 2006).
It has been shown that the inhibitory effects of senescence onFigure 3 Effect of the cell cycle inhibitor p21 on reprogramming effi
(p21) mRNA levels in long term-cultured fibroblasts (passage 25) (n = 3;
t-test). B) Relative expression of CDKN1A (p21) for all fibroblasts (age 0–8
qPCR, and fold changes were calculated relative to neonatal fibroblasts
analysis of p21 protein levels from the fibroblasts of 14-year old and 81-ye
Western blot of p21 for neonatal fibroblasts at passage 20. CTRL, control;
E) Schematic presentation of p21 knockdown experiment. Fibroblasts we
daily basis, starting five days prior to SeV infection and lasting until iPSC
(siRNAp21) on the growth of late passage fibroblasts. Data presented is co
(N = 3). The cells were counted at days 0 and 7. G) Effect of p21 knoc
fibroblasts (combined from 0-, 1-, 81-, and 83-year old donors, passage
Supplementary Fig. 3B. H) Representative image of AP staining at day 21
p21 knockdowns with untreated control. Panels on the right show TRA-1-
(black square). Bright field (BF), TRA-1-60 (green), alkaline phosphatase (
old) is shown in Supplementary Fig. 3A and B.reprogramming can be overcome by inhibition of p53 pathway
(Banito et al., 2009; Hong et al., 2009; Kawamura et al., 2009;
Li et al., 2009; Rasmussen et al., 2014; Utikal et al., 2009;
Zhao et al., 2008). In addition, supplementing reprogramming
media with vitamin C has been shown to significantly improve
the reprogramming efficiency of senescent cells (Esteban et
al., 2010).
Next we wanted to determine if we could rescue the
reprogramming efficiency of late passage (p28) fibroblasts
from young (0 and 1-year) and old (81 and 83-year) donors by
inhibiting the p53/p21 pathway by siRNA-mediated knock-
down of p21. First we verified that the siRNA against p21 was
indeed able to strongly reduce the P21 protein level in
passaged fibroblasts (Fig. 3D). To alleviate senescence in
passaged fibroblasts we started transfections of siRNA against
p21 five days prior to reprogramming. Daily transfections
continued until day 14, when we were able to visualize newly
formed iPSC colonies (Fig. 3E). The addition of p21 siRNA
significantly increased the number of fibroblasts during
the first days of reprogramming (Fig. 3F). The pluripotent
reprogramming efficiency of late passage fibroblasts was
studied by counting AP-positive iPSC colonies with hESC-like
morphology, and live staining for stem cell surface marker
TRA-1-60, 16–21 days after the induction. Knockdown of p21
was able to rescue the reprogramming efficiency of late
passage fibroblasts derived from all donors (Fig. 3G and H and
Supplementary Fig. 3A and B). This is in striking contrast to the
standard condition in which no iPSC colonies were detected
from old (81 and 83-year) donor fibroblasts.
Finally, in order to show conclusively that p21 directly
controls reprogramming efficiency, we overexpressed p21
for the entire duration of the experiment in fibroblasts from
0 and 1-year old donors at passages 7 and 2 respectively
(Supplementary Fig. 3D). Overexpression of p21 resulted in
suppression of growth of transfected fibroblasts, which was
expected based on the previous reports (el-Deiry et al.,
1993; Harper et al., 1995; Xiong et al., 1993), and no iPSC
colonies were generated (Supplementary Fig. 3E and F).
In conclusion, our results demonstrate that fibroblasts
obtained from both young and old donors can give rise to
iPSC. However, young and early passage fibroblasts yield the
highest reprogramming efficiency, while advanced donor
age and time in culture induce a synergistic negative effectciency in passaged fibroblasts A) Significant upregulation of CDKN1A
three independent experiments. ***p b 0.001, **p b 0.01; Student's
3) at passage 6 (n = 3). Relative expression levels were measured by
at passage 6, after normalization to Cyclophilin G. C) Western blot
ar old donors at passages 2, 8, and 18. D) Knockdown of p21 by siRNA.
siRNA p21, passage 20 cells treated with siRNA against p21 for 72 h.
re transfected without vector (CTRL) or with siRNA against p21 on a
colonies were clearly visible (day 14). F) Effect of p21 knockdown
mbined from 0-, 81-, and 83-year old donor fibroblasts at passage 25
kdown (siRNAp21) on the reprogramming efficiency of late passage
25, N = 4). Reprogramming efficiencies for each line are shown in
after the start of induction of fibroblasts at passage 25 comparing to
60 and AP staining of the same iPSC colony, enlarged from picture H
AP). Data for all passage 25 fibroblast donors (0-, 1-, 81-, and 83-year
260 R. Trokovic et al.
261Combined effect of age and culture time on reprogramming efficiencymarkedly reducing the number of iPSC colonies. The nega-
tive effect of donor age and time in culture on repro-
gramming efficiency appears to be associated with cellular
senescence mediated primarily by upregulation of the cell
cycle inhibitory protein p21. Our results demonstrate that
iPSC generation can be enhanced even from late passage
human fibroblasts from old donors through inhibition of p21
during the reprogramming process.
Supplementary data to this article can be found online at
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